![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
EA Austin and BE Huber
Wellcome Research Labs, Research Triangle Park, North Carolina 27709.
We have developed a new approach involving gene therapy for the treatment of primary and metastatic tumors in the liver. As a first step toward the development of this gene therapy treatment for metastatic colorectal carcinoma, the Escherichia coli gene that encodes cytosine deaminase (CD) (EC 3.5.4.1) has been cloned. By using positive genetic selection, a plasmid carrying a 10.8-kilobase BamHI/EcoRI DNA insert was isolated that had CD enzymatic activity. Genetic screening, followed by enzymatic assays, identified a 3-kilobase DNA fragment that retained CD activity. Deamination of cytosine and 5-fluorocytosine (5- FC) by cloned CD was demonstrated. DNA and protein sequencing identified an open reading frame of 427 amino acids that encodes CD. To demonstrate that expression of CD in eukaryotic cells allows metabolism of the nontoxic prodrug 5-FC to the toxic metabolite 5-fluorouracil, CD was cloned into a eukaryotic expression vector and transfected into a human colorectal carcinoma cell line. Growth inhibition studies showed a shift in the IC50 for 5-FC from 17,000 microM in the parental cell line to 30 microM in cells expressing CD.
This article has been cited by other articles:
|
|
 |
|
  J.-C. Tseng, P. B. Zanzonico, B. Levin, R. Finn, S. M. Larson, and D. Meruelo Tumor-Specific In Vivo Transfection with HSV-1 Thymidine Kinase Gene Using a Sindbis Viral Vector as a Basis for Prodrug Ganciclovir Activation and PET J. Nucl. Med., July 1, 2006; 47(7): 1136 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Nyati, A. Sreekumar, S. Li, M. Zhang, S. D. Rynkiewicz, A. M. Chinnaiyan, A. Rehemtulla, and T. S. Lawrence High and Selective Expression of Yeast Cytosine Deaminase under a Carcinoembryonic Antigen Promoter-Enhancer Cancer Res., April 1, 2002; 62(8): 2337 - 2342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kanyama, N. Tomita, T. Yamano, T. Aihara, Y. Miyoshi, M. Ohue, M. Sekimoto, I. Sakita, Y. Tamaki, Y. Kaneda, et al. Usefulness of Repeated Direct Intratumoral Gene Transfer Using Hemagglutinating Virus of Japan-Liposome Method for Cytosine Deaminase Suicide Gene Therapy Cancer Res., January 1, 2001; 61(1): 14 - 18. [Abstract] [Full Text]
|
|
|
|
|
|
M. Simonova, A. Wall, R. Weissleder, and A. Bogdanov Jr. Tyrosinase Mutants Are Capable of Prodrug Activation in Transfected Nonmelanotic Cells Cancer Res., December 1, 2000; 60(23): 6656 - 6662. [Abstract] [Full Text]
|
|
|
|
|
|
P. Erbs, E. Regulier, J. Kintz, P. Leroy, Y. Poitevin, F. Exinger, R. Jund, and M. Mehtali In Vivo Cancer Gene Therapy by Adenovirus-mediated Transfer of a Bifunctional Yeast Cytosine Deaminase/Uracil Phosphoribosyltransferase Fusion Gene Cancer Res., July 1, 2000; 60(14): 3813 - 3822. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Wyss and R. Kaddurah-Daouk Creatine and Creatinine Metabolism Physiol Rev, July 1, 2000; 80(3): 1107 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Morris Enzyme/Prodrug-Based Tumor Vaccination: All Politics (and Immunity) Are Local J Natl Cancer Inst, December 1, 1999; 91(23): 1986 - 1989. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kasono, J. L. Blackwell, J. T. Douglas, I. Dmitriev, T. V. Strong, P. Reynolds, D. A. Kropf, W. R. Carroll, G. E. Peters, R. P. Bucy, et al. Selective Gene Delivery to Head and Neck Cancer Cells via an Integrin Targeted Adenoviral Vector Clin. Cancer Res., September 1, 1999; 5(9): 2571 - 2579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kievit, E. Bershad, E. Ng, P. Sethna, I. Dev, T. S. Lawrence, and A. Rehemtulla Superiority of Yeast over Bacterial Cytosine Deaminase for Enzyme/Prodrug Gene Therapy in Colon Cancer Xenografts Cancer Res., April 1, 1999; 59(7): 1417 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wei and B. E. Huber Cytosine Deaminase Gene as a Positive Selection Marker J. Biol. Chem., February 16, 1996; 271(7): 3812 - 3816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Sikora Current Issues in Cancer: Genes dreams and cancer BMJ, May 7, 1994; 308(6938): 1217 - 1221. [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
